The major impacts of James Black's drug discoveries on medicine and pharmacology

Trends in Pharmacological Sciences

Volumn 32, Issue 4, 2011, Pages 183-188

  Walker, Michael J A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROPRANOLOL;

ACHIEVEMENT; ANALYTIC METHOD; ANGINA PECTORIS; ANXIETY DISORDER; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; DRUG SYNTHESIS; ESSENTIAL TREMOR; GLAUCOMA; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HIGH THROUGHPUT SCREENING; HUMAN; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; MORBIDITY; MORTALITY; PANIC; PEPTIC ULCER; PHARMACOLOGICAL BLOCKING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; TREMOR;

ADRENERGIC BETA-ANTAGONISTS; CIMETIDINE; DRUG DISCOVERY; HISTAMINE H2 ANTAGONISTS; HISTORY, 20TH CENTURY; HUMANS; PHARMACOLOGY; PROPRANOLOL; RESEARCH;

EID: 79954417242     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2011.02.001     Document Type: Review

References (41)

1. J. Black A life in new drug research Br. J. Pharmacol. 160 2010 S15 S25
2. J.W. Black Pharmacological resultant - analytical challenge and therapeutic strategy Acta Pharmacol. Toxicol. 59 1986 123
3. J.W. Black Pharmacology - analysis and exploration Br. Med. J. 293 1986 252 255
4. J.W. Black Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant Br. J. Pharmacol. 89 1986 547 555 (Pubitemid 16008393)
5. J.W. Black, and P. Leff Operational models of pharmacological agonism Proc. R. Soc. Ser. B 220 1983 141 162 (Pubitemid 14217337)
6. J.W. Black, and N.P. Shankley Interpretation of agonist affinity estimations - the question of distributed receptor states Proc. R. Soc. Sci. Ser. B 240 1990 503 518 (Pubitemid 20206538)
7. E.A. Harper Analysis of variation in L-365,260 competition curves in radioligand binding assays Br. J. Pharmacol. 151 2007 109 124
8. 1 adrenoceptor-mediated pressor activity Nauyn-Schmiedeberg's Arch. Pharmacol. 354 1996 389 392 (Pubitemid 26284508)
9. J. Black Drugs from emasculated hormones: the principle of syntopic antagonism Science 245 1989 486 493 (Pubitemid 19203998)
10. 1-like receptor agonists and the pathophysiology of migraine Trends Pharmacol. Sci. 10 1989 200 204 (Pubitemid 19158378)
11. B. Munos Lessons from 60 years of pharmaceutical innovation Nat. Rev. Drug Disc. 8 2009 959 968
12. J.W. Black, and N.P. Shankley Inverse agonists exposed Nature (Lond.) 374 1995 214 215
13. D.G. Kramer Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction J. Am. Coll. Cardiol. 56 2010 392 406
14. β-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction J. Am. Med. Assoc. 250 1983 2814 2819
15. M.C. Shibata Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure Eur. J. Heart Failure 3 2001 351 357 (Pubitemid 32895844)
16. S.M. Hart Influence of beta-blockers on mortality in chronic heart failure Ann. Pharmacother. 34 2000 1440 1451
17. M.P. Stapleton Sir James Black and propranolol Tex. Heart Inst. J. 24 1997 336 342
18. B.N. Pritchard Propranolol in the treatment of angina: a review Postgrad. Med. J. 52 Suppl. 4 1976 35 41
19. C.S.U. Wiysonge Beta blockers for hypertension Cochrane Database Syst. Rev. 2007 2007 CD002003
20. D.M. Lambert Effect of propranolol on mortality in patients with angina Postgrad. Med. J. 52 Suppl. 4 1976 57 60
21. P.J. Snow Effect of propranolol in myocardial infarction Lancet 18 1965 551 553
22. N. Freemantle β blockade after myocardial infarction: systematic review and meta regression analysis Br. Med. J. 318 1999 1730 1737 (Pubitemid 29290470)
23. N.A. Hanania The safety and effects of the beta blocker, nadalol, in mild asthma: an open-label pilot study Pulm. Pharmacol. Ther. 21 2008 134 141
24. D.D. Sin, and S.F. Man A curious case of β blockers in chronic obstructive pulmonary disease Arch. Intern. Med. 170 2010 849 850
25. S.R. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst. Rev. 2005 2005 CD003566
26. J.W. Black Sulphur-methylene isomerism in development of metiamide, a new histamine Hs-receptor antagonist Nature (Lond.) 248 1974 65 67
27. J.W. Black Definition and antagonism of histamine H2 receptors Nature (Lond.) 236 1972 385 390
28. A.G. Wilson Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol Br. Med. J. 4 1969 399 401
29. C.V.S. Ram Beta-blockers in hypertension Am. J. Cardiol. 106 2010 1819 1828
30. W.S. Aronow Current role of beta-blockers in the treatment of hypertension Expert Opin. Pharmacother. 11 2010 2599 2607
31. J.M. Foody β-Blocker therapy in heart failure J. Am. Med. Assoc. 287 2002 883 889
32. F. Gorre, and H. Vandekerckhove Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 65 2010 565 570
33. S. Bangalore Cardiovascular protection using beta-blockers: a critical review of the evidence J. Am. Coll. Cardiol. 50 2007 563 572 (Pubitemid 47202065)
34. L.A. Sorbera Therapeutic targets for glaucoma Drugs Future 35 2010 585 592
35. T.J. Zimmerman, and W.P. Boger III The beta adrenergic blocking agents and the treatment of glaucoma Surv. Ophthalmol. 23 1979 347 362 (Pubitemid 9199790)
36. T.A. Zesiewicz Overview of essential tremor Neuropsychiatr. Dis. Treat. 6 2010 401 408
37. A. Fumarola Medical treatment of hyperthyroidism: state of the art Exp. Clin. Endocrinol. Diabetes 118 2010 678 684
38. D.T. Williams Phaeochromocytoma - views on current management Eur. J. Surg. Oncol. 29 2003 483 490 (Pubitemid 37009964)
39. S.D. Silberstein Preventive migraine treatment Neurol. Clin. 27 2009 429 443
40. M.A. Zamorski, and R.C. Albucher What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder Am. Fam. Phys. 66 2002 1477 1484 (Pubitemid 35402542)
41. J.R.T. Davidson Pharmacotherapy of social anxiety disorder J. Clin. Psychiatry 59 1998 47 51 (Pubitemid 28487514)